Washington: Metformin, the drug commonly administered in diabetes, has shown a promise in extending the lifespan of patients with ovarian cancers, say findings from a new study conducted by Indian-American medical researchers.New treatments are desperately needed for ovarian cancer patients. A previous research has indicated that metformin, which originates from the French Lilac plant, may have anti-cancer properties.Viji Shridhar and Sanjeev Kumar, both from the Mayo Clinic in Rochester, and their colleagues analyzed the data collected from 61 patients with ovarian cancer who took metformin, and 178 patients who did not, the journal CANCER reports.Sixty-seven percent of those who took metformin had not died from ovarian cancer within five years, compared with 47 percent of those who did not take the medication, according to a Mayo Clinic statement.
J&K: Pakistan Army violates ceasefire
Imran Khan, Qadri march into Islamabad`s `red zone`
Varanasi: PM Modi`s mini PMO to be inaugurated
PM Narendra Modi addresses DRDO scientists, stresses on innovation and technology